Douglas Simmons

Douglas Simmons has extensive experience in statistical programming within the pharmaceutical industry, currently serving as Associate Director at Biogen since October 2018, where oversight includes leading a programming team to align with therapeutic area milestones across drug programs. Prior roles include Associate Director of Statistical Programming at Bristol-Myers Squibb and Pfizer, with a focus on late-stage clinical trials and global drug development respectively. Douglas has managed SAS programming teams, ensured compliance with regulatory submissions, and contributed to study design and analysis at various organizations, showcasing a strong blend of technical leadership and collaborative team management. Educational credentials include a B.A. in Mathematics and Statistics from the University of Vermont and an MS in Biostatistics from Virginia Commonwealth University School of Medicine.